Inhibition of adhesion and metastasis of HepG2 hepatocellular carcinoma cells in vitro by DNA aptamer against sialyl Lewis X

Abstract

The sialyl Lewis X (SLe^x) antigen encoded by the FUT7 gene is the ligand of endotheliam-selectin (E-selectin). The combination of SLe^x antigen and E-selectin represents an important way for malignant tumor metastasis. In the present study, the effect of the SLe^x-binding DNA aptamer on the adhesion and metastasis of hepatocellular carcinoma HepG2 cells in vitro was investigated. Reverse transcription-polymerase chain reaction (RT-PCR) and immunofluorescence staining were conducted to detect the expression of FUT7 at both transcriptional and translational levels. The SLe^x expression in HepG2 cells treated with different concentrations of SLe^x-binding DNA aptamer was detected by flow cytometry. Besides, the adhesion, migration, and invasion of HepG2 cells were measured by cell adhesion assay, and the Transwell migration and invasion assay. The results showed that the FUT7 expression was up-regulated at both mRNA and protein levels in HepG2 cells. SLe^x-binding DNA aptamer could significantly decrease the expression of SLe^x in HepG2 cells. The cell adhesion assay revealed that the SLe^x-binding DNA aptamer could effectively inhibit the interactions between E-selectin and SLe^x in the HepG2 cells. Additionally, SLe^x-binding DNA aptamers at 20 nmol/L were found to have the similar effect to the monoclonal antibody CSLEX-1. The Transwell migration and invasion assay revealed that the number of penetrating cells on the down-side of Transwell membrane was significantly less in cells treated with 5, 10, 20 nmol/L SLe^x-binding DNA aptamer than those in the negative control group (P<0.01). Our study demonstrated that the SLe^x-binding DNA aptamer could significantly inhibit the in vitro adhesion, migration, and invasion of HepG2 cells, suggesting that the SLe^x-binding DNA aptamer may be used as a potential molecular targeted drug against metastatic hepatocellular carcinoma.

Keywords

sialyl Lewis X / DNA aptamer / hepatocellular carcinoma / metastasis

References

[1] TorreLA, BrayF, SiegelRL, et al. . Global cancer statistics, 2012. CA Cancer J Clin, 2015, 65(2): 87-108 PMID: 25651787

[2] ShahMH, SaingerRN, TelangSD, et al. . E-Cadherin truncation and sialyl Lewis-X overexpression in oral squamous cell carcinoma and oral precancerous conditions. Neoplasma, 2009, 56(1): 40-47 PMID: 19152244

[3] BevilacquaMP, StengelinS, GimbroneMA, et al. . Endothelial leukocyte adhesion molecule-1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science, 1989, 243(4895): 1160-1165 PMID: 2466335

[4] HillCAS, Baharo-HassanD, FarooquiM. C2-O-sLe X glycoproteins are E-selectin ligands that regulate invasion of human colon and hepatic carcinoma cells. PloS one, 2011, 6(1): 16281

[5] ShirureVS, HensonKA, SchnaarRL, et al. . Gangliosides expressed on breast cancer cells are E-selectin ligands. Biochem Biophys Res Commun, 2011, 406(3): 423-429 PMID: 21329670

[6] BelovL, ZhouJ, ChristophersonRI. Cell surface markers in colorectal cancer prognosis. Int J Mol Sci, 2010, 12(1): 78-113 PMID: 21339979 PMCID: 3039945

[7] PolleyMJ, PhillipsML, WaynerE, et al. . CD62 and endothelial cell-leukocyte adhesion molecule 1 (ELAM-1) recognize the same carbohydrate ligand, sialyl-Lewis x. Proc Natl Acad Sci, 1991, 88(14): 6224-6228 PMID: 1712483 PMCID: 52055

[8] KhatibAM, KontogianneaM, FallavollitaL, et al. . Rapid induction of cytokine and E-selectin expression in the liver in response to metastatic tumor cells. Cancer Res, 1999, 59(6): 1356-1361 PMID: 10096570

[9] ZhangB, ChenH, YaoX, et al. . E-selectin and its ligand-sLeX in the metastasis of hepatocellular carcinoma. Zhonghua Wai Ke Za Zhi (Chinese), 2000, 38(7): 534-536

[10] kunoK, KawaiI, HiraiN, et al. . Role of sialyl Lewis X in liver metastasis in view of liver-associated immunity. Hepato-Gastroenterol, 2003, 50(51): 756-760

[11] AnnagiR, IzawaM, KoikeT, et al. . Carbohydrate-mediated cell adhesion in cancer metastasis and angiogenesis. Cancer Sci, 2004, 95(5): 377-384

[12] LäubliH, BorsigL. Selectins promote tumor metastasis. Semin Cancer Biol, 2010, 20(3): 169-177 PMID: 20452433

[13] ShirureVS, HensonKA, SchnaarRL, et al. . Gangliosides expressed on breast cancer cells are E-selectin ligands. Biochem Biophys Res Commun, 2011, 406(3): 423-429 PMID: 21329670